Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability

被引:8
作者
Edeline, Julien [1 ,3 ]
Coulouarn, Cedric [3 ]
Crouzet, Laurence [1 ,3 ]
Pracht, Marc [1 ]
Lepareur, Nicolas [2 ,3 ]
Clement, Bruno [3 ]
Garin, Etienne [2 ,3 ]
机构
[1] Ctr Eugene Marquis, Dept Med Oncol, F-35043 Rennes, France
[2] Ctr Eugene Marquis, Dept Nucl Med, F-35043 Rennes, France
[3] INSERM, UMR991, Rennes, France
关键词
IN-VITRO DEMONSTRATION; CANCER; RADIOEMBOLIZATION; CHEMOTHERAPY;
D O I
10.1016/j.jvir.2015.06.032
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Synergy between yttrium-90 (Y-90) and antineoplastic drugs was investigated. Viability of HepaRG (hepatocellular carcinoma) and HuCCT1 (cholangiocarcinoma) cells was studied through a tetrazolium dye reduction assay. A combination index (CI) was calculated, with CI < 1 denoting synergy and CI > 1 denoting antagonism. In HepaRG cells, gemcitabine showed synergy with Y-90 (CI = 0.70 [95% confidence interval = 0.65-0.75]), whereas oxaliplatin (CI = 1.15 [1.08-1.21]), paclitaxel (CI = 1.26 [1.15-1.37]), and sorafenib (CI = 1.77 [1.65-1.89]) showed antagonism In HuCCT1 cells, gemcitabine (CI = 0.54 [0.50-0.58]) and oxaliplatin (CI = 0.86 [0.82-0.90]) showed synergy with Y-90, whereas paclitaxel (CI = 1.18 [1.09-1.27]) and sorafenib (CI = 1.21 [1.12-1.30]) showed antagonism. These results suggest that gemcitabine and oxaliplatin should be tested in combination with Y-90 radioembolization for treatment of liver cancer.
引用
收藏
页码:1874 / 1878
页数:5
相关论文
共 15 条
[1]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199
[2]   Pilot Study of Angiogenic Response to Yttrium-90 Radioembolization with Resin Microspheres [J].
Carpizo, Darren R. ;
Gensure, Rebekah H. ;
Yu, Xin ;
Gendel, Vyacheslav M. ;
Greene, Samuel J. ;
Moore, Dirk F. ;
Jabbour, Salma K. ;
Nosher, John L. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (02) :297-306
[3]  
Chenoufi N, 1998, J NUCL MED, V39, P900
[4]   Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells [J].
Cuconati, Andrea ;
Mills, Courtney ;
Goddard, Cally ;
Zhang, Xianchao ;
Yu, Wenquan ;
Guo, Haitao ;
Xu, Xiaodong ;
Block, Timothy M. .
PLOS ONE, 2013, 8 (01)
[5]   Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients [J].
Cuneo, Kyle C. ;
Davis, Mary A. ;
Feng, Mary U. ;
Novelli, Paula M. ;
Ensminger, William D. ;
Lawrence, Theodore S. .
TRANSLATIONAL ONCOLOGY, 2014, 7 (04) :472-478
[6]   Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines [J].
Iwahashi, Shuichi ;
Ishibashi, Hiroki ;
Utsunomiya, Tohru ;
Morine, Yuji ;
Ochir, Tovuu Lkhaguva ;
Hanaoka, Jun ;
Mori, Hiroki ;
Ikemoto, Tetsuya ;
Imura, Satoru ;
Shimada, Mitsuo .
JOURNAL OF MEDICAL INVESTIGATION, 2011, 58 (1-2) :106-109
[7]  
Kupcsik L, 2011, METHODS MOL BIOL, V740, P13, DOI 10.1007/978-1-61779-108-6_3
[8]   Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma [J].
Lambert, Bieke ;
De Ridder, Leo ;
De Vos, Filip ;
Slegers, Guido ;
de Gelder, Virginie ;
Van de Wiele, Christophe ;
Thierens, Hubert .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2006, 84 (10) :1021-1028
[9]   Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis [J].
Mouli, Samdeep ;
Memon, Khairuddin ;
Baker, Talia ;
Benson, Al B., III ;
Mulcahy, Mary F. ;
Gupta, Ramona ;
Ryu, Robert K. ;
Salem, Riad ;
Lewandowski, Robert J. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (08) :1227-1234
[10]  
Pracht M, 2013, ANTICANCER RES, V33, P3871